HPRA Drug Safety Newsletter Edition 81

Download: hpra-drug-safety-newsletter-edition-81.pdf 242 KB

  The latest edition of the HPRA Drug Safety Newsletter (DSN) includes important updates to support the safe and appropriate use of the following medicines:

Valproate (Epilim) and Developmental Disorders: Update on ongoing EU review

Domperidone-containing medicines: reminder of the risk of cardiac adverse reactions-restricted indication, contraindications and reduced dose and duration of use

New CPD e-learning module on reporting suspected adverse drug reactions

Direct Healthcare Professional Communications published on the HPRA website since the last Drug Safety Newsletter

« Back